The healthcare sector is outperforming the broader market and tech sector in Q4, confirming a substantial capital shift into ...
Pharmaceutical Technology on MSN
Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility
"Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility" was originally created and published by ...
reported better-than-expected earnings for the fourth quarter. The Indianapolis, Indiana-based company posted quarterly earnings of $428.5 million, or $0.40 per share, compared to $727.5 million, or ...
Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...
Eli Lilly to invest $6 billion in new synthetic medicine facility in Huntsville, AL to boost domestic production and create ...
Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook is strong, and the stock is a buy, even at current levels. Eli Lilly's (NYSE ...
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results